Related Experiment Video
Updated: Jun 1, 2026

10:55
Digital Microfluidics for Automated Proteomic Processing
Published on: November 6, 2009
Enhancing protease activity assay in droplet-based microfluidics using a biomolecule concentrator
Chia-Hung Chen1, Aniruddh Sarkar, Yong-Ak Song
1Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 36-841, 77 Massachusetts Avenue, Cambridge Massachusetts 02139, USA.
Journal of the American Chemical Society
|June 16, 2011
Summary
This study presents a microfluidic device that concentrates biomolecules, improving enzyme assays for detecting low-abundance targets like matrix metalloproteinases (MMPs). The platform significantly reduces assay time and sample volume.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Biochemistry
Background:
- Enzyme assays often face sensitivity limitations, especially with low-abundance analytes.
- Detecting biomarkers like matrix metalloproteinases (MMPs) at ultralow concentrations is crucial for early disease diagnosis.
- Existing methods may require large sample volumes or extended assay times.
Purpose of the Study:
- To develop an integrated microfluidic device for enhanced sensitivity in enzyme assays.
- To concentrate biomolecules prior to droplet microreactor encapsulation.
- To apply the platform for detecting ultralow levels of matrix metalloproteinases (MMPs).
Main Methods:
- Integration of a biomolecule concentrator and a microdroplet generator on a single microfluidic chip.
- Utilizing droplet microreactors for high-throughput and controlled reaction environments.
- Application of the device to analyze diluted cellular supernatant for MMP detection.
Main Results:
- The microfluidic device significantly enhances the sensitivity of low-abundance enzyme assays.
- Biomolecule pre-concentration within the device improved detection limits for matrix metalloproteinases (MMPs).
- A ~10-fold reduction in assay completion time and sample volume was achieved.
Conclusions:
- The developed microfluidic platform offers a powerful tool for sensitive detection of low-abundance enzymes.
- This technology addresses key limitations in current enzyme assay methodologies.
- The device shows promise for applications requiring rapid and efficient biomarker detection from minimal sample volumes.

